NYSEARCA:LABU Direxion Daily S&P Biotech Bull 3x Shares (LABU) Price, Holdings, & News → Biden out June 13? (From Paradigm Press) (Ad) Free LABU Stock Alerts $125.64 +0.34 (+0.27%) (As of 09:45 AM ET) Add Compare Share Share Today's Range$122.18▼$127.3050-Day Range$110.91▼$174.1252-Week Range$48.40▼$176.99Volume455,256 shsAverage Volume3.14 million shsMarket Capitalization$21.83 billionAssets Under Management$1.11 billionDividend Yield0.16%Net Expense Ratio0.96% Stock AnalysisStock AnalysisChartHeadlinesHoldingsOwnershipRatingsStock AnalysisChartHeadlinesHoldingsOwnershipRatings Get Direxion Daily S&P Biotech Bull 3x Shares alerts: Email Address About Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABU)The Direxion Daily S&P Biotech Bull 3X Shares (LABU) is an exchange-traded fund that is based on the S&P Biotechnology Select Industry index. The fund provides daily 3 times exposure to the S&P Biotechnology Select Industry Index. LABU was launched on May 28, 2015 and is managed by Direxion.Read More LABU Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart LABU ETF News HeadlinesMarch 10, 2024 | americanbankingnews.comDirexion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABU) Trading Up 6.1%March 4, 2024 | seekingalpha.comLABU: A Really Bad DriftMarch 19, 2024 | InvestorPlace (Ad)They said crypto was dead. It went up 100X.Bitcoin’s haters are out again. Despite the price doubling in the last six months alone… That hasn’t stopped the experts from piling on. Warren Buffett’s right-hand man Charlie Munger called crypto investors “idiots” in one of his last interviews. JPMorgan CEO Jamie Dimon, recently called Bitcoin a “pet rock” and “a hyped-up fraud.” But when it comes to cryptos, these are exactly the people you shouldn’t listen to. They’ve predicted crypto’s demise for years.January 22, 2024 | finance.yahoo.comDirexion Daily S&P Biotech Bull 3X Shares (LABU)December 16, 2023 | seekingalpha.comLABU: Buy As The Biotech Sector Starts A New Bull Market (Technical Analysis)December 10, 2023 | seekingalpha.comLABU: Tool For Swing TradersNovember 4, 2023 | msn.comUVXY, LABU and NAIL among weekly ETF moversNovember 3, 2023 | finance.yahoo.comDirexion Announces Reverse Splits of TMF and LABUMarch 19, 2024 | Colonial Metals (Ad)Central Bank Gold Heist In ProgressWhen central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago.September 29, 2023 | msn.comLABU And LABD: Another Attractive Double-Short Pairs TradeSee More Headlines Receive LABU Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Direxion Daily S&P Biotech Bull 3x Shares and its competitors with MarketBeat's FREE daily newsletter. Email Address Fund Details IssuerDirexion Fund NameDirexion Daily S&P Biotech Bull 3x Shares Tax ClassificationRegulated Investment Company Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:LABU Inception Date5/28/2015 Fund ManagerPaul Brigandi, Tony Ng WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkS&P Biotechnology Select Industry Index CategorySector FocusHealth Care Development LevelDeveloped Markets RegionNorth America Number of Holdings141 Fund Statistics Assets Under Management$1.18 billion Average Daily Volume$2.01 million Discount/Premium0.07% Leveraged3.00 Administrator, Advisor and Custodian AdministratorU.S. Bancorp Fund Services, LLC AdvisorRafferty Asset Management, LLC CustodianThe Bank of New York Mellon Corporation DistributorForeside Fund Services, LLC Transfer AgentThe Bank of New York Mellon Corporation TrusteeN/A Lead Market MakerVirtu Financial Options OptionableOptionable Options Volume6,950 Put Options3,531 Call Options3,419 Short Interest848,800 shs Miscellaneous Outstanding Shares173,760,000Beta3.00 Creation Unit50,000 Creation Fee$250.00 7 Energy Stocks to Buy and Hold ForeverDo you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.Get This Free Report Ad Weiss RatingsThe ONE AI sSock to own now. (It’s not Nvidia.)Don’t panic — you haven’t missed the boat on AI. In fact, it has barely launched. Sure, the early stages of this boom were big … But I believe the real wealth in AI has yet to be made …Click here to see the presentation now. Direxion Daily S&P Biotech Bull 3x Shares ExpensesTypeLABUHealth Care ETFsEquity ETFsNYSEARCA ETFsAll ETFsManagement Fee0.75%0.57%0.54%0.50%0.51%Other Expenses0.21%0.40%0.54%0.64%0.58%Total Expense0.96%0.72%0.70%0.74%0.70%Fee Waiver0.00%-0.53%-0.54%-0.68%-0.56%Net Expense0.96%0.61%0.60%0.57%0.58% Direxion Daily S&P Biotech Bull 3x Shares (LABU) Holdings & ExposureTop 10 LABU HoldingsDreyfus Govt Cash Man InsHolding Weight: 15.07%Goldman Sachs Sterling FixInc Port IncHolding Weight: 6.29%S&P Biotechnology Select Industry Index SwapHolding Weight: 6.28%CashHolding Weight: 3.73%Dreyfus Trsry Securities Cash MgmtHolding Weight: 2.15%BridgeBio Pharma(NASDAQ:BBIO)Holding Weight: 1.61%Citi CollateralHolding Weight: 1.60%Goldman Sachs Fin Gov 465 InstitutHolding Weight: 1.31%Revolution Medicines(NASDAQ:RVMD)Holding Weight: 1.03%Halozyme Therapeutics(NASDAQ:HALO)Holding Weight: 1.02%LABU Sector ExposureLABU Industry ExposureFull Holdings Details Similar ETFsFirst Trust NYSE Arca Biotechnology Index FundNYSEARCA:FBTFirst Trust Health Care AlphaDEX FundNYSEARCA:FXHInvesco S&P 500 Equal Weight Health Care ETFNYSEARCA:RSPHInvesco S&P 500 Equal Weight Health Care ETFNYSEARCA:RYHiShares U.S. Healthcare Providers ETFNYSEARCA:IHFInstitutional OwnershipGoldman Sachs Group Inc.Bought 9,741 shares on 3/1/2024Ownership: 0.006%Barclays PLCBought 151,615 shares on 2/15/2024Ownership: 0.087%Wolverine Trading LLCSold 84,900 shares on 2/15/2024Ownership: 0.000%GTS Securities LLCSold 325,300 shares on 2/15/2024Ownership: 0.000%HAP Trading LLCSold 34,300 shares on 2/15/2024Ownership: 0.000%View All Institutional Transactions LABU ETF - Frequently Asked Questions How have LABU shares performed in 2024? Direxion Daily S&P Biotech Bull 3x Shares' stock was trading at $121.97 at the beginning of the year. Since then, LABU shares have increased by 3.0% and is now trading at $125.64. View the best growth stocks for 2024 here. What does LABU invest in? Direxion Daily S&P Biotech Bull 3x Shares is a equity fund issued by Direxion. LABU focuses on health care investments and follows the S&P Biotechnology Select Industry Index. The fund's investments total to approximately $1.11 billion assets under management. What stocks does Direxion Daily S&P Biotech Bull 3x Shares hold? LABU invests in 169 holdings. Some of the stocks in their portfolio include BridgeBio Pharma (BBIO), Revolution Medicines (RVMD), Halozyme Therapeutics (HALO), ACADIA Pharmaceuticals (ACAD), Catalyst Pharmaceuticals (CPRX), Neurocrine Biosciences (NBIX), Novavax (NVAX), AbbVie (ABBV), Incyte (INCY) and Vertex Pharmaceuticals (VRTX). What is the management fee for Direxion Daily S&P Biotech Bull 3x Shares? Direxion Daily S&P Biotech Bull 3x Shares' management fee is 0.75% and has other expenses of 0.21%. The net expense ratio for LABU is 0.96%. When did Direxion Daily S&P Biotech Bull 3x Shares' stock split? Direxion Daily S&P Biotech Bull 3x Shares shares reverse split on the morning of Monday, December 4th 2023. The 1-20 reverse split was announced on Monday, December 4th 2023. The number of shares owned by shareholders was adjusted after the market closes on Monday, December 4th 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split. What other stocks do shareholders of Direxion Daily S&P Biotech Bull 3x Shares own? Based on aggregate information from My MarketBeat watchlists, some companies that other Direxion Daily S&P Biotech Bull 3x Shares investors own include Micron Technology (MU), NVIDIA (NVDA), Direxion Daily S&P Biotech Bear 3x Shares (LABD), Alibaba Group (BABA), ProShares UltraPro QQQ (TQQQ), Advanced Micro Devices (AMD), Direxion Daily Semiconductors Bull 3x Shares (SOXL), Boeing (BA), Gilead Sciences (GILD). Who are Direxion Daily S&P Biotech Bull 3x Shares' major shareholders? Direxion Daily S&P Biotech Bull 3x Shares' stock is owned by a number of institutional and retail investors. Top institutional shareholders include Citadel Advisors LLC (0.00%), Barclays PLC (0.09%), Wolverine Trading LLC (0.00%), GTS Securities LLC (0.00%), Tower Research Capital LLC TRC (0.02%) and Cutler Group LLC CA (0.00%). How do I buy shares of Direxion Daily S&P Biotech Bull 3x Shares? Shares of LABU stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSEARCA:LABU) was last updated on 3/19/2024 by MarketBeat.com Staff From Our PartnersCentral Bank Gold Heist In ProgressColonial MetalsLike Tiny Crypto Retirement FundsCrypto 101 MediaBiden out June 13?Paradigm PressMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceSHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceThe world’s greatest investmentPorter & CompanyBuy this small stock before coming AI Tidal WaveChaikin AnalyticsStock-Picking AI Predicts #1 Stock of 2024Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Direxion Daily S&P Biotech Bull 3x Shares Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.